Skip to content

Evaluation of Carbohydrates Part 2

Evaluation of Carbohydrates (CHO): Tolerance, Breath Hydrogen and Methane

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03293706
Enrollment
13
Registered
2017-09-26
Start date
2017-09-21
Completion date
2017-11-15
Last updated
2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastro-Intestinal Tolerance

Brief summary

The study is single-blind with a randomized, cross-over design to evaluate gastrointestinal tolerance of carbohydrate blends.

Interventions

mixed in 237 ml/8 fl. oz. of a flavored non-caloric beverage; 1 time consumption

mixed in 237 ml/8 fl. oz. of a flavored non-caloric beverage; 1 time consumption

mixed in 237 ml/8 fl. oz. of a flavored non-caloric beverage; 1 time consumption

mixed in 237 ml/8 fl. oz. of a flavored non-caloric beverage; 1 time consumption

mixed in 237 ml/8 fl. oz. of a flavored non-caloric beverage; 1 time consumption

Sponsors

Abbott Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Males or non-pregnant females in good health. * Eligible to receive income in Canada and must demonstrate OHIP or equivalent medical coverage.

Exclusion criteria

* Subject with any type of food allergy or with a known history of AIDS, hepatitis, diabetes, cardio-vascular disease or GI disease. * Subject taking medication, or with any condition which might, in the opinion of the PI either make participation dangerous to the subject or to others or affect the results.

Design outcomes

Primary

MeasureTime frameDescription
Breath hydrogen0 to 7 hoursAssessed in exhaled gasses

Secondary

MeasureTime frameDescription
GI tolerance symptoms0 to 48 hoursAssessed using a subject tolerance questionnaire

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026